COVID-19 Vaccination Willingness and Acceptability in Multiple Sclerosis Patients: A Cross Sectional Study in IranArticle Published on 2022-01-172022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] acceptability affected age Analysis cause Central nervous system clinical study Comorbidities Comorbidity correlation COVD-19 COVID-19 COVID-19 vaccination cross-sectional degenerative demographic data demographic factor disease drug Efficacy evaluate expressed Factors healthcare providers Immune-mediated immunomodulatory immunosuppressive medications information Innate immunity Iran Major majority media multicenter Multiple multiple sclerosis participant Patient patients questionnaire reducing refusal sclerosis SPSS software the vaccine These data vaccination Vaccine vaccine acceptability Vaccine hesitancy vaccine willingness was performed [DOI] 10.3390/vaccines10010135 PMC 바로가기 [Article Type] Article
Atypical Kawasaki Disease after COVID-19 Vaccination: A New Form of Adverse Event Following ImmunizationCase Report Published on 2022-01-162022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] Adverse AEFI Anxiety Atypical Case report clinician college condition COVID-19 COVID-19 vaccine criteria disease events form identify immunization Intravenous immunoglobulin Kawasaki disease kidney dysfunction liver manifested medium vessels New Patient patients reaction reported SARS-CoV-2 Symptom the vaccine therapy Vaccine Vaccine reaction Vaccines Vasculitis Vaxzevria Viral vector [DOI] 10.3390/vaccines10010126 PMC 바로가기 [Article Type] Case Report
Predictors and Perceptions of Healthcare Workers Regarding Vaccines Safety in the Initial Phase of COVID-19 Vaccination Drive in Western Part of India: A Regression AnalysisAllergy/Immunology Published on 2022-01-152022-10-31 Journal: Cureus [Category] COVID-19, [키워드] age association Care conducted COVID-19 COVID-19 infection COVID-19 patient COVID-19 vaccination COVID-19 vaccine cross-sectional dependent on drive Effect effective Effects Government Health professionals healthcare healthcare worker India injection majority male MOST other variables Pain Part Patient care Perception phase Regression regression analysis reported Result Safe Safety statistically significant subject the timing the vaccine vaccination Vaccine Vaccine acceptance Vaccine hesitancy was used worker [DOI] 10.7759/cureus.21267 PMC 바로가기 [Article Type] Allergy/Immunology
Effectiveness of the CoronaVac® vaccine in a region of the Colombian Amazon, was herd immunity achieved?Short Report Published on 2022-01-152022-10-28 Journal: Tropical Diseases, Travel Medicine and Vaccines [Category] COVID-19, [키워드] age applied Brazil carried country COVID-19 COVID-19 vaccines death determine disease dose Effectiveness evaluated Hospitalization Immunity immunization strategy immunized in some individual mass vaccination Mild Mortality mortality rate objective post-exposure prevention Prophylaxis public health reduce reported SARS-CoV-2 SARS-CoV-2 vaccine Severe infection shown the vaccine vaccinated individual vaccinated individuals vaccination Vaccine variants of interest [DOI] 10.1186/s40794-021-00159-x PMC 바로가기 [Article Type] Short Report
Impact of Coronavirus Infectious Disease (COVID-19) pandemic on willingness of immunization—A community-based questionnaire studyResearch Article Published on 2022-01-142022-10-28 Journal: PLoS ONE [Category] COVID-19, [키워드] 95% CI change conducted confirmed case COVID-19 cross-sectional disease Government greater Health immunization Impact Infectious disease Influenza knowledge pandemic participant pneumococcal pneumococcus positive attitude question questionnaire receive receiving Result Sociodemographic characteristics Taiwan the vaccine vaccination Vaccine Vaccines [DOI] 10.1371/journal.pone.0262660 PMC 바로가기 [Article Type] Research Article
Safety of the BNT162b2 mRNA COVID-19 vaccine in oncologic patients undergoing numerous cancer treatment options A retrospective single-center study5700 Published on 2022-01-142022-10-30 Journal: Medicine [Category] COVID-19, [키워드] active cancer Administered biologic BNT162b2 mRNA Cancer cancer patient cancer treatment caused Chemotherapy COVID-19 COVID-19 pandemic COVID-19 vaccine diagnose Diagnosis died dose FIVE Hospitalization Hospitalized identify Immune checkpoint inhibitors Immunotherapy incidence Local Mild moderate outcomes participant Patient Prevalence protocol Radiation released reported retrospective Safe Safety SARS-CoV2 severe disease Side effect single center single-center study systemic side effect the vaccine therapy Treatment Type undergo Vaccine vaccine safety virus [DOI] 10.1097/MD.0000000000028561 PMC 바로가기 [Article Type] 5700
Vaccination Schedule under Conditions of Limited Vaccine Production RateArticle Published on 2022-01-132022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] approved caused Community condition COVID-19 pandemic COVID-19 vaccination Decision-making distribution experiment group herd immune Herd immunity threshold Immunity include Infection International Limited mathematical model optimization pandemic Probability Production Protective Rate reported schedule scheduling stratified the vaccine vaccination vaccination schedule Vaccine Vaccines [DOI] 10.3390/vaccines10010116 PMC 바로가기 [Article Type] Article
Potential Anionic Substances Binding to Platelet Factor 4 in Vaccine-Induced Thrombotic Thrombocytopenia of ChAdOx1-S Vaccine for SARS-CoV-2Immunology Published on 2022-01-122022-11-01 Journal: Frontiers in Immunology [Category] COVID-19, [키워드] Adenovirus Analysis anionic anionic substances antibodies Antigen association autoantibody ChAdOx1-S ChAdOx1-S vaccine characterized component DNA Express expressed Factor FIVE glycoprotein PF4 Potential Protein Proteins recent SARS-CoV-2 substance susceptible individual the S protein the vaccine thrombocytopenia thrombosis thrombotic triggered tween vaccination Vaccine vaccine-induced thrombotic thrombocytopenia (VITT) Venous thrombosis [DOI] 10.3389/fimmu.2021.782335 PMC 바로가기 [Article Type] Immunology
Side Effects and Efficacy of COVID-19 Vaccines among the Egyptian PopulationArticle Published on 2022-01-122022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] antibody BBIBP-CorV BioNTech BNT162 ChAdOx1 Coronavirus infection COVID-19 COVID-19 vaccine detect Dizziness dose doses Effect effective Efficacy fatigue Fever first dose greater headache immune response Immunity indicated injection Mild moderate MOST Pain participant Population produced Safe second dose severity side Side effect Side-effect the vaccine vaccination Vaccine vaccine antibodies vaccine efficacy vaccine side effects Vaccines virus was collected [DOI] 10.3390/vaccines10010109 PMC 바로가기 [Article Type] Article
A model of factors influencing COVID-19 vaccine acceptance: A synthesis of the theory of reasoned action, conspiracy theory belief, awareness, perceived usefulness, and perceived ease of useResearch Article Published on 2022-01-122022-10-28 Journal: PLoS ONE [Category] COVID-19, [키워드] age authority collected contribute COVID-19 vaccination COVID-19 vaccine develop equation Factor Google immunization individual key factor modeling Pandemics Partial positive positive attitude Prevent PROTECT questionnaire reduce square the vaccine vaccination Vaccine was used [DOI] 10.1371/journal.pone.0261869 PMC 바로가기 [Article Type] Research Article